Early detection for lung cancer. New tools for casefinding.

Area of Science:

• Pulmonology
• Oncology
• Radiology

Background:

• Lung cancer risk persists long after smoking cessation, especially in individuals with chronic obstructive pulmonary disease.
• Current Canadian guidelines, based on outdated trials, do not recommend sputum cytology or chest radiography (CXR) for lung cancer screening in asymptomatic adults.
• Early-stage lung cancer is treatable, underscoring the need for effective early detection methods.

Purpose of the Study:

• To review existing data on lung cancer screening from population trials and clinical guidelines.
• To provide recommendations for the early detection of lung cancer.

Main Methods:

• Literature search of MEDLINE using keywords: "lung neoplasm," "mass screening," "thoracic radiography," and "sputum."
• Selection of prospective randomized controlled trials with large participant numbers.

Main Results:

• Canadian guidelines advise against sputum cytology and CXR for asymptomatic lung cancer screening due to limitations in older studies.
• Symptomatic current and former smokers over 45 with a significant smoking history and airflow obstruction may benefit from CXR and sputum cytology.
• Recent technological advancements include low-dose spiral CT and improved sputum tests for early lung cancer detection, with ongoing research.

Conclusions:

• Primary care physicians play a crucial role in identifying individuals at high risk for lung cancer.
• Supporting research for new lung cancer screening technologies is essential for improving early detection and patient outcomes.